Advanced healthcare materials
Engineered Therapeutic Nanoplatforms for Ischemic Heart Disease Treatment Vis Cardiac Microenvironment Reprogramming.
Hui Xiao, Wenjia Zhang, Jian Liu, Yixue Ma, Donghao Liu, Mengmeng Li, Rui Xin, Liangcan He, Shaoqin Liu
Published: 202610.1002/adhm.202503560
Abstract
Ischemic heart disease (IHD), the leading cause of death worldwide, progresses through acute, transitional, and end-stage phases, forming a "oxidative stress-inflammation-fibrosis" vicious cycle. Current therapies face major limitations: reperfusion,…
Preview only. Read the full abstract at the source